IndiaTickerAnalysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Company dossier
Aarti Drugs
NSE:AARTIDRUGS · ISIN INE767A01016
- Close
- ₹411.25 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarti Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Action(s) taken or orders passed - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Closure Directions By GPCBBSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Trading Window - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Copy of Newspaper Publication - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Transfer Of Equity Shares Of The Company To IEPFBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Copy of Newspaper Publication - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Investor Presentation - Aarti Drugs LimitedNSE · investor presentation · pdf
Source filing Aarti Drugs Ltd - 524348 - Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Aarti Drugs Ltd - 524348 - Re-Appointment Of Cost Auditor And Internal AuditorBSE · exchange filing · pdf
Source filing Aarti Drugs Ltd - 524348 - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 15, 2026BSE · financial results · pdf
Source filing General Updates - Aarti Drugs LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Aarti Drugs LimitedNSE · financial results · pdf
Source filing Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Aarti Drugs LimitedNSE · conference call · pdf
Source filing Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing